Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kura Oncology, Inc. | CCO & Chief Strategy Officer | Common Stock | 20.6K | $237K | $11.50 | Jan 27, 2023 | Direct |
Comera Life Sciences Holdings, Inc. | Director | Warrant (Right to Buy) | 13.5K | $3.38K | $0.25 | Jan 4, 2023 | Direct |
Comera Life Sciences Holdings, Inc. | Director | Warrants (right to buy) | 13.5K | $3.38K | $0.25 | Jan 4, 2023 | Direct |
Comera Life Sciences Holdings, Inc. | Director | Common Stock | 22.2K | $1.57K | $0.07 | Jan 4, 2023 | Direct |
Comera Life Sciences Holdings, Inc. | Director | Stock Option (Right to Purchase) | 111K | Nov 9, 2023 | Direct | ||
PMV Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 67.5K | Jun 6, 2024 | Direct | ||
Comera Life Sciences Holdings, Inc. | Director | Stock Option (Right to Buy) | 45K | May 19, 2022 | Direct |